Research Article| Volume 172, ISSUE 5, P418-424, November 1996

Download started.


Glutamine, cancer, and its therapy

      This paper is only available as a PDF. To read, Please Download here.


      This overview on glutamine, cancer and its therapy discusses some of the in vitro and in vivo work on glutamine and tumor growth, and summarizes animal and human data on the potential benefits of glutamine in the tumor-bearing host receiving radiation or chemotherapy.


      Glutamine is the most abundant amino acid in the body. A tumor can act as a “glutamine trap,” depleting host glutamine stores and resulting in cachexia. In vitro evidence of the dependence of tumor growth on glutamine has deterred its use in the clinic setting.


      Data from a variety of investigations studying glutamine's interaction with the tumorbearing host receiving radiation or chemotherapy were compiled and summarized.


      A large body of evidence in vivo suggests that supplemental glutamine does not make tumors grow but in fact results in decreased growth through stimulation of the immune system. When given with radiation or chemotherapy, glutamine protects the host and actually increases the selectivity of therapy for the tumor.


      Further prospective randomized trials are needed to demonstrate the safety and efficacy in humans undergoing radiation and chemotherapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Askanazi J
        • Furst P
        • Michelson CB
        • et al.
        Muscle and plasma amino acids after injury, hypocaloric glucose versus amino acid infusion.
        Ann Surg. 1980; 191: 465-472
        • Kovacevic Z
        • Morris HP
        The role of glutamine in the oxidative Cty metabolism of malignant cells.
        Cancer Res. 1972; 32: 326-333
        • Windmueller HG
        Glutamine utilization by the small intestine.
        Adv Enzymol. 1982; 53: 202
        • Ardawi MSM
        • Newsholme EA
        Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance.
        Biochem J. 1982; 208: 743
        • Zeilke RH
        • Ozand PT
        • Tildon JT
        Reciprocal regulation of glucose w and glutamine utilization by cultured human diploid fibroblasts.
        J Cell Physiol. 1978; 95: 41-46
        • Knox WE
        • Horowitz ML
        • Friedell GH
        The proportionality of w glutaminase content to growth rate and morphology of rat neoplasms.
        Cancer Res. 1969; 29: 669-680
        • Welbourne TC
        Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney.
        Can J Biochem. 1979; 57: 233-237
        • Fox AD
        • Kripke SA
        • DePaula J
        • et al.
        Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis.
        JPEN. 1988; 12: 325-331
        • Klimberg VS
        • Souba WW
        • Dolson DJ
        • Copeland EM
        Oral glutamine supports crypt cell turnover and accelerates intestinal healing following abdominal radiation.
        JPEN. 1989; : 34
        • Klimberg VS
        • Souba WW
        • Salloum RM
        • et al.
        Glutamine enriched diets support muscle glutamine metabolism without stimulating tumor growth.
        J Surg Res. 1990; 48: 319-323
        • Klimberg VS
        • Nwokedi E
        • Hutchins LF
        • et al.
        Does glutamine facilitate chemotherapy while reducing its toxicity?.
        in: Surg Forum. 42. 1991: 16-18
        • Fahr M
        • Kornbluth J
        • Blossom S
        • et al.
        GLN enhances immunoregulation of tumor growth.
        JPEN. 1994; 18: 471
        • Bergstrom J
        • Furst P
        • Noree LO
        • Vinnars E
        Intracellular free amino acid concentrations in human muscle tissue.
        J Appl Physiol. 1974; 36: 693-697
        • Windmueller HG
        • Spaeth AE
        Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats.
        J Biol Chem. 1980; 225: 107-112
        • Vinnars E
        • Bergstrom J
        • Furst P
        Influence of the postoperative state on the intracellular free amino acids in human muscle tissue.
        Ann Surg. 1975; 182: 665-671
        • Chen MK
        • Austgen TR
        • Klimberg VS
        • et al.
        Tumor glutamine use exceeds intestinal glutamine use in cachectic tumor-bearing rats.
        in: Surg Forum. LI. 1990: 12-14
        • Cao Y
        • Feng Z
        • Klimberg VS
        Glutamine enhances gut glutathione production.
        in: Presented at ASPEN, Washington, DCJanuary 1996
        • Hong R
        • Rounds J
        • Helton W
        GLN preserves liver GSH after lethal hepatic injury.
        Ann Surg. 1992; 215: 114
        • Rouse K
        • Nwokedi E.
        • Woodliff J
        • et al.
        Glutamine enhance selectivity of chemotherapy through changes in glutathione metabolism.
        Ann Surg. 1995; 221: 420-426
        • Souba W
        • Strebel F
        • Bul J
        • et al.
        Interorgan GLN metabolism in the tumor-bearing rat.
        J Surg Res. 1988; 44: 720
        • Jepson MM
        • Bates PC
        • Broadbent P
        • et al.
        Relationship between glutamine concentration and protein synthesis in rat skeletal muscle.
        Am J Physiol. 1988; 255 (pt 1): E166-E172
        • Klimberg VS
        • Kornbluth J
        • Cao Y
        • et al.
        Glutamine suppresses PGE2 synthesis and breast cancer growth.
        J Surg Res. 1996; (In press)
        • Klimberg VS
        • Pappas AA
        • Nwokedi E
        • et al.
        Effect of GLN on tumor concentrations of MTX.
        Arch Surg. 1992; 27: 1317
        • Jensen J
        • Schaefer R
        • Nwokedi E
        • et al.
        Dietary glutamine prevents chronic radiation enteropathy.
        Ann Surg Oncol. 1993; 1: 157-163
        • Jensen JC
        • Nwokedi E
        • Baker ML
        • et al.
        Glutamine supports host while decreasing tumor glutathione after radiation injury.
        in: Presented at the Association for Academic Surgery 26th Annual Meeting, Montreal, Quebec, CanadaNovember 1992
        • Klimberg VS
        • Gregory M
        • Blossom S
        • Baker M
        Oral glutamine enhances radiosensitivity in rat sarcoma.
        in: Presented at the Society of Surgical Oncology, Houston, Texas1994
        • Alverdy JC
        Effect of glutamine-supplemented diets on immunology of the gut..
        JPEN. 1990; 14 (suppl): 109S-113S
        • Juretic A
        • Spagnoli GC
        • Horig H
        • et al.
        GLN requirements in the generation of LAK cells.
        Clin Nutr. 1994; 13: 42
        • Liang C
        • Cattill D
        • Liang S
        GSH regulates IL-2 activity on cytotoxic T-cells.
        J Biol Chem. 1989; 264: 13519
        • Herberman RB
        • Ortaldo JR
        NK cells: their role in defense against disease.
        Science. 1981; 214: 24-28
        • Markovic SN
        • Murasko DM
        Inhibition of induction of natural killer activity in mice by general anesthesia (avertin) : role of interferon.
        Clin Immunol Immunopathol. 1991; 60: 181-189
        • Rosenberg SA
        • Lotze MT
        • Muul LM
        • et al.
        A progress report on the treatment of 157 patients with advanced camcer using LAK cells and IL-2 or high-dose IL-2 alone.
        NEJM. 1987; 316: 889-897
        • Baxevanis CN
        • Reclos GJ
        • Gritzapis AD
        • et al.
        Elevated PGE2 production by monocytes is responsible for the depressed levels of NK & LAK cell function in patients with breast cancer.
        Cancer. 1993; 12: 491-501
        • Buckley BJ
        • Kent RS
        • Whorton AR
        Regulation of endothelial cell prostaglandin synthesis by glutathione.
        J Biol Chem. 1991; 266: 16659-16666
        • Chance WT
        • Cao L
        • Fischer JE
        Response of tumor and host to hyperalimentation and antiglutamine treatments.
        JPEN. 1990; 14: 122128
        • Ziegler TR
        • Benfell K
        • Smith RJ
        • et al.
        Safety and metabolic effects of L-glutamine administration in humans.
        JPEN. 1990; 14 (suppl): 137S-146S
        • Schloerb PR
        • Amare M
        Total patenterai nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study).
        JPEN. 1993; 17: 407-413
        • Ziegler TR
        • Young LS
        • Benfell K
        • et al.
        Glutamine-supplemented parenteral nutrition improves nitrogen retention and reduces hospital mortality versus standard parenteral nutrition following bone marrow transplantation: a randomized, double-blind trial.
        Ann Intern Med. 1992; 116: 821-828
        • Skubitz KM
        • Anderson PM
        Oral glutamine to prevent k chemotherapy induced stomatitis: a pilot study.
        J Lab Clin Med. 1996; 127: 223-228
        • Richards EW
        • Long CL
        • Pinkston JA
        • et al.
        The role of oral glutamine supplementation in the prevention of radiation-induced enterocolitis in prostate cancer patients.
        FASEB J. 1992; 6: A1680